From the latest cancer paper of Dr P . Posted on I
Post# of 148179
Conclusions
In summary, a biomarker or set of biomarkers, as we have identified in this pilot study that identifies drug targets on cells within the tumor microenvironment that have inhibitory effects on the anti-tumor immune response like T-regs is critically important to devise multi-drug treatment strategies that will potentially provide long-lasting response in a higher percentage of patients. These data await large scale, placebo controlled trials to confirm clinical relevance.